This article summarizes the most important insider buying and selling activities reported in US stocks on Tuesday, October 8, 2024.
Top Insider Buys:
• FrontView REIT, Inc. (NYSE:FVR): Alyeska Investment Group, a significant shareholder of FrontView REIT, Inc., increased its stake in the company. The investment group bought 810,810 shares worth about $15.5 million at an average price of $19.11. The transactions were completed on October 3, 2024, with multiple acquisitions of 135,135 shares each. This large investment shows Alyeska's continued confidence in the future prospects of the real estate investment trust.
• Eton Pharmaceuticals Inc. (NASDAQ: ): Opaleye Management Inc., the largest shareholder in Eton Pharmaceuticals, strengthened its position in the company through a series of stock purchases worth approximately $434,000. The transactions took place over several days, with share prices ranging between $6.771 and $7.2235. These purchases were made on behalf of Opaleye's managed fund, Opaleye, LP, and a separately managed account, demonstrating the investment manager's continued commitment to the healthcare sector.
• Mueller Water Products, Inc. (NYSE:NYSE:): Brian C. Healy, director at Mueller Water Products, made significant purchases of the company's stock on October 7. Healy acquired 1,125 shares at an average price from $21.91 to $21.99, for a total investment of $24,738. The transaction was conducted in accordance with the Rule 10b5-1 trading plan, which Healy had previously executed on May 15, 2024, indicating a pre-arranged method of acquisition of his stock.
• Tile Shop (NASDAQ:) Holdings, Inc. (NASDAQ:TTSH): Investment firms associated with Pleasant Lake Partners increased its stake in Tile Shop Holdings, a company specializing in home furnishings and appliance sales. The entities, including Pleasant Lake Onshore Feeder Fund LP, Fund 1 Investments, LLC, and Pleasant Lake Partners LLC, collectively purchased more than $78,000 worth of stock. The acquisition took place in two separate transactions on October 4 and October 8, 2024, with share prices ranging between $6.4202 and $6.4332.
• AngioDynamics Inc. (NASDAQ:): James C. Clemmer, President and CEO of AngioDynamics, has made a significant purchase of the company's stock. On October 7, Clemmer acquired 20,000 shares at an estimated net price of $6.03 per share, totaling an investment of $120,600. The transaction, which included purchases at prices ranging from $5.95 to $6.08, increased Clemmer's total ownership in the medical device company to 681,582 shares.
Top Insider Sells:
• Trade Desk, Inc. (NASDAQ:): Jeffrey Terry Green, President and CEO of Trade Desk, Inc., sold a large amount of the company's Class A Common Stock. The total value of the transactions reached $45,052,383, with share prices ranging from $111.75 to $113.35. The sale was made over two days, October 4 and October 7, 2024, at various weighted prices.
• MoonLake Immunotherapeutics (NASDAQ:MLTX): The management of Biotechnology Value Fund LP and related parties have divested a significant amount of shares in MoonLake Immunotherapeutics. On October 4, 2024, they sold a total of 2,053,000 Class A Common Shares at a price of $50.0016 per share, amounting to $100,003,200. Selling companies include Biotechnology Value Fund II LP, BVF Partners LP/IL, and other related entities.
• Apple Inc. (NASDAQ:): Luca Maestri, Senior Vice President and Chief Financial Officer of Apple Inc., sold a majority of the company's stock. On October 4, 2024, Maestri sold 59,305 shares at an average price of $226.52, a total of approximately $13.43 million. The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan, which Maestri had adopted on November 11, 2023.
• Boston Scientific Corp (NYSE:BSX): Joseph Michael Fitzgerald, Senior Vice President and Group President of Cardiology at Boston Scientific Corp, sold a large number of shares. Fitzgerald disposed of 132,527 shares at an average price of $85.00, with sales ranging from $85.00 to $85.01 per share. The total number of shares traded amounted to $11,264,887. This transaction was part of a previously established trading plan.
• Boston Scientific Corporation (NYSE:NYSE:): Michael F. Mahoney, Chairman, President, and CEO of Boston Scientific Corporation, made a significant stock transaction. On October 7, Mahoney sold 162,777 shares for a total value of more than $13.7 million, with individual sales prices ranging from $84.31 to $84.94. Additionally, Mahoney acquired 111,886 shares through stock option exercises, valued at approximately $1.88 million, at prices between $16.31 and $17.26. This transaction was conducted under the previously established Rule 10b5-1 trading system.
Staying informed about insider buying and selling activities can provide valuable information to investors. These transactions may provide clues about the company's future, as insiders often have different information about their company's performance and outlook. However, it is important to remember that insider trading can occur for a variety of reasons and should not be the only basis for investment decisions. Always consider many different factors and do thorough research before making any investment decisions.
This article was created with the support of AI and reviewed by an editor. For more information see our T&C.
